Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals

被引：5
|
作者：
Ntanasis-Stathopoulos, Ioannis [1 ]
Karalis, Vangelis [2 ]
Sklirou, Aimilia D. [3 ]
Gavriatopoulou, Maria [1 ]
Alexopoulos, Harry [3 ]
Malandrakis, Panagiotis [1 ]
Trougakos, Ioannis P. [3 ]
Dimopoulos, Meletios A. [1 ]
Terpos, Evangelos [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Hlth Sci, Sect Pharmaceut Technol, Dept Pharm, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens, Greece
来源：
HEMASPHERE | 2022年 / 6卷 / 07期
关键词：
D O I：
10.1097/HS9.0000000000000747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Lower virus neutralizing titers against SARS-CoV-2 Omicron strain after third dose BNT162b2 following primo-vaccination with ChAdOx1 versus BNT162b2 in cancer patients
    Debie, Y.
    Van Audenaerde, J.
    Vandamme, T.
    Croes, L.
    Teuwen, L-A. M. N.
    Verbruggen, L.
    Vanhoutte, G.
    Marcq, E.
    Le Blon, D.
    Peeters, B.
    Goossens, M. E.
    Arien, K.
    Anguille, S.
    Smits, E.
    Vulsteke, C.
    Lion, E.
    Peeters, M.
    van Dam, P. A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1305 - S1305
  • [22] Immunological responses following the third dose of the BNT162b2 SARS-CoV-2 vaccine among Japanese healthcare workers
    Tamura, Miku
    Fujita, Retsu
    Sato, Tomoaki
    Sato, Ryohei
    Kato, Yasuyuki
    Nagasawa, Mitsuaki
    Matsumoto, Tetsuya
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (11) : 1478 - 1482
  • [23] The breadth and neutralizing activity of SARS-CoV-2 antibodies among children 6 months to 4 years of age following vaccination with mRNA-1273 or BNT162b2
    Williams, Caitlin
    Dalapat, Trisha
    Giorgi, Elena
    Hurst, Jillian
    Herbek, Savannah
    Chen, Jui-Lin
    Kosman, Christina
    Rotta, Alexandre
    Turner, Nicholas
    Pulido, Natalie
    Aquino, Jhoanna
    Pfeiffe, Trevor
    Rodriguez, Javier
    Permar, Sallie
    Fouda, Genevieve
    Kelly, Matthew
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [24] Herpes zoster infection following SARS-CoV-2 vaccine BNT162b2
    Lauro, Wanda
    Cillo, Francesco
    Nastro, Francesca
    Fabbrocini, Gabriella
    Marasca, Claudio
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2023, 158 (04) : 364 - 365
  • [25] Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naive and previously infected individuals
    Muena, Nicolas A.
    Garcia-Salum, Tamara
    Pardo-Roa, Catalina
    Jose Avendano, Maria
    Serrano, Eileen F.
    Levican, Jorge
    Almonacid, Leonardo, I
    Valenzuela, Gonzalo
    Poblete, Estefany
    Strohmeier, Shirin
    Salinas, Erick
    Munoz, Andres
    Haslwanter, Denise
    Dieterle, Maria Eugenia
    Jangra, Rohit K.
    Chandran, Kartik
    Gonzalez, Claudia
    Riquelme, Arnoldo
    Krammer, Florian
    Tischler, Nicole D.
    Medina, Rafael A.
    EBIOMEDICINE, 2022, 78
  • [26] Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients
    El Haggan, Wael
    Berdin, Bruno
    El Salhy, Magdy
    CLINICAL KIDNEY JOURNAL, 2022, 15 (06) : 1202 - 1203
  • [27] BNT162b2 Vaccination after SARS-CoV-2 Infection Changes the Dynamics of Total and Neutralizing Antibodies against SARS-CoV-2: A 6-Month Prospective Cohort Study
    Hernandez-Bello, Jorge
    Sierra-Garcia-de-Quevedo, Jose Julio
    Morales-Nunez, Jose Javier
    Santoscoy-Ascencio, Guillermo
    Diaz-Perez, Saul Alberto
    Gutierrez-Brito, Jesus Alberto
    Munoz-Valle, Jose Francisco
    VACCINES, 2023, 11 (06)
  • [28] Acute hemorrhagic leukoencephalitis following the first dose of BNT162b2 vaccine against SARS-CoV-2: A case report
    Kalafatakis, Konstantinos
    Margoni, Anna
    Liakou, Maria-Eleni
    Stenos, Christos
    Toulas, Panagiotis
    Korkolopoulou, Penelope
    Lakiotaki, Eleftheria
    Lafazanos, Spiridon A.
    Zekiou, Katerina
    Kardara, Panagiota
    Terentiou, Aspasia
    Nikolaou, Georgios
    Stouraitis, Georgios
    HELIYON, 2024, 10 (03)
  • [29] Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer
    Debie, Yana
    Van Audenaerde, Jonas R. M.
    Vandamme, Timon
    Croes, Lieselot
    Teuwen, Laure-Anne
    Verbruggen, Lise
    Vanhoutte, Greetje
    Marcq, Elly
    Verheggen, Lisa
    Le Blon, Debbie
    Peeters, Bart
    Goossens, Maria E.
    Pannus, Pieter
    Arien, Kevin K.
    Anguille, Sebastien
    Janssens, Annelies
    Prenen, Hans
    Smits, Evelien L. J.
    Vulsteke, Christof
    Lion, Eva
    Peeters, Marc
    Dam, Peter A. van
    CLINICAL CANCER RESEARCH, 2023, 29 (03) : 635 - 646
  • [30] Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection
    Niesen, Michiel J. M.
    Matson, Robert
    Puranik, Arjun
    O'Horo, John C.
    Pawlowski, Colin
    Vachon, Celine
    Challener, Douglas
    Virk, Abinash
    Swift, Melanie
    Speicher, Leigh
    Gordon, Joel
    Geyer, Holly
    Lenehan, Patrick J.
    Venkatakrishnan, A. J.
    Soundararajan, Venky
    Badley, Andrew
    PNAS NEXUS, 2022, 1 (02):
12345